Clerk Finance Department at Degage Furniture

The Purpose of This Post Is To ALERT You That The Job You Are About To APPLY TO or May Have Applied For or is CONSIDERING APPLYING FOR Is Fraudulent. A LEGITIMATE COMPANY IDENTITY HAS BEEN STOLEN OR A BOGUS ONE CREATED

These job postings are an attempt to lure you into cashing counterfeit checks and have you wire funds via Western Union or MoneyGram -Essentially You Become A Money or RePackage Mule

Money Mule Explained

Read All About This at Symantec Corp.

Job Snapshot
Location: New York, NY E
Employee Type: Part-Time Employee
Industry: manufacturer of furniture
Manages Others: No
Job Type: employee of financial department
Education: High School
Experience: unessential

Description : Clerk Finance Department (Part Time)

Degage contemporary home furnishings. We are a manufacturer of a high quality line of contemporary furniture and neo-classical home furnishings located in Phoenix, Arizona. Degage specializes in contemporary bedroom and entertainment centers but we also design tables, dining sets, pedastools and desks

ESSENTIAL JOB FUNCTIONS (examples of work):
Work with regional managers.
Processing of demands from regional managers.
The help to regional managers in registration of the order for company production.
Performance of commissions of regional managers.
Conducting the account of demands of regional managers.
Report drawing up under the executed orders of regional managers.
Other projects or cross training as assigned
Proficient in MS Word, Email, Internet
Self motivated with the ability to effectively prioritize multiple simultaneous tasks
Responsibility, Punctuality
Ability to work with financial and bank documents
Training to skills of work with financial documents is possible

MINIMUM QUALIFICATIONS
High School graduate or equivalent
Age from 22 years
SALARY RATE: $2300- $3,540 per month +5%( Percent from sales)

We need representative in your area,it might be you: Royal Inc

Company Name Royal Inc

Job Category Customer Service; Sales
Location Bellevue, WA
Position Type Part-Time, Contract
Salary $1,000 to $2,500 per year + 300
Experience 0-1 Years Experience
Desired Education Level High School
Date Posted July 24, 2009

HELLO TO EVERYONE,

NOW WE HAVE THE OFFER FOR EVERYONE THAT HAS THE INTEREST TO WORK IN THEIR AREA.

WE HAVE ALL KINDS OF WORK TO OFFER, WE ARE A COMPANY THAT THAT NEED PEOPLE TO WORK FOR THEM…

WE HAVE ALL KINDS OF EASY,PROFITING, STRESS FREE WORK,
WHEN WE GIVE YOU WHAT WE GOT, YOU TELL US WHAT YOU CAN DO..

MAIL US AT … NEWFIRM@MAIL2ROYAL.COM

OR LIVE YOUR MESSAGE ON 206-338-4371

Who Are Pharma Dropshipper – pharmadropship.com

Buying Precription Drugs Online May Be Dangerous
– Consumer Alert –
Drug Enforcement Administration Says

warning1

National Association of Boards of Pharmacy (NABP)

Warning

“The Canadian Pharmacy, Canadian/European Pharmacy”, “Canadian Healthcare” and “US Drugstore” are brands of one of the most disgusting illegal online pharmacy group well organized CRIMINAL OPERATION of all times. “GREED” is the driving force behind this operation. Don’t let them fool you. They will never send you any genuine drugs. If they ever send anything at all, it may consist of literally anything from sugar to wall plaster, and they certainly don’t care that you will endanger your health by taking those dangerous counterfeit drugs.

Behind The Online Pharma

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharma world.

PharmaDropShipper

Address lookup

canonical name pharmadropship.com.
aliases
addresses 174.143.0.178

Domain Whois record

Queried whois.internic.net with “dom pharmadropship.com“…

   Domain Name: PHARMADROPSHIP.COM
   Registrar: GODADDY.COM, INC.
   Whois Server: whois.godaddy.com
   Referral URL: http://registrar.godaddy.com
   Name Server: NS0.DNSMADEEASY.COM
   Name Server: NS1.DNSMADEEASY.COM
   Name Server: NS2.DNSMADEEASY.COM
   Name Server: NS3.DNSMADEEASY.COM
   Name Server: NS4.DNSMADEEASY.COM
   Status: clientDeleteProhibited
   Status: clientRenewProhibited
   Status: clientTransferProhibited
   Status: clientUpdateProhibited
   Updated Date: 19-oct-2008
   Creation Date: 24-nov-2007
   Expiration Date: 24-nov-2009

>>> Last update of whois database: Sun, 26 Jul 2009 16:31:48 UTC <<<

Queried whois.godaddy.com with “pharmadropship.com“…

Registrant:
   pronet ltd

   Registered through: GoDaddy.com, Inc. (http://www.godaddy.com)
   Domain Name: PHARMADROPSHIP.COM

   Domain servers in listed order:
      NS0.DNSMADEEASY.COM
      NS1.DNSMADEEASY.COM
      NS2.DNSMADEEASY.COM
      NS3.DNSMADEEASY.COM
      NS4.DNSMADEEASY.COM

   For complete domain details go to:

Network Whois record

Queried whois.arin.net with “!NET-174-143-0-176-1“…

CustName:   ProNet
Address:    9725 Datapoint
City:       San Antonio
StateProv:  TX
PostalCode: 78225
Country:    US
RegDate:    2009-02-13
Updated:    2009-02-13

NetRange:   174.143.0.176 - 174.143.0.183 
CIDR:       174.143.0.176/29 
NetName:    RSPC-1234538289621055
NetHandle:  NET-174-143-0-176-1
Parent:     NET-174-143-0-0-1
NetType:    Reassigned
Comment:    
RegDate:    2009-02-13
Updated:    2009-02-13

RAbuseHandle: ABUSE45-ARIN
RAbuseName:   Abuse Desk 
RAbusePhone:  +1-210-892-4000
RAbuseEmail:  abuse@rackspace.com 

RTechHandle: IPADM17-ARIN
RTechName:   IPADMIN 
RTechPhone:  +1-210-892-4000
RTechEmail:  ipadmin@rackspace.com 

OrgAbuseHandle: ABUSE45-ARIN
OrgAbuseName:   Abuse Desk 
OrgAbusePhone:  +1-210-892-4000
OrgAbuseEmail:  abuse@rackspace.com

OrgTechHandle: IPADM17-ARIN
OrgTechName:   IPADMIN 
OrgTechPhone:  +1-210-892-4000
OrgTechEmail:  ipadmin@rackspace.com

OrgTechHandle: ZR9-ARIN
OrgTechName:   Rackspace, com 
OrgTechPhone:  +1-210-892-4000
OrgTechEmail:  hostmaster@rackspace.com

# ARIN WHOIS database, last updated 2009-07-25 20:00

DNS records

DNS query for 178.0.143.174.in-addr.arpa returned an error from the server: NameError

name class type data time to live
pharmadropship.com IN A 174.143.0.178 1800s (00:30:00)
pharmadropship.com IN SOA
server: ns0.dnsmadeeasy.com
email: dns.dnsmadeeasy.com
serial: 2008010112
refresh: 43200
retry: 3600
expire: 1209600
minimum ttl: 180
86400s (1.00:00:00)
pharmadropship.com IN MX
preference: 10
exchange: mx1.emailsrvr.com
1800s (00:30:00)
pharmadropship.com IN MX
preference: 20
exchange: mx2.emailsrvr.com
1800s (00:30:00)
pharmadropship.com IN NS ns1.dnsmadeeasy.com 86400s (1.00:00:00)
pharmadropship.com IN NS ns0.dnsmadeeasy.com 86400s (1.00:00:00)
pharmadropship.com IN NS ns4.dnsmadeeasy.com 86400s (1.00:00:00)
pharmadropship.com IN NS ns3.dnsmadeeasy.com 86400s (1.00:00:00)
pharmadropship.com IN NS ns2.dnsmadeeasy.com 86400s (1.00:00:00)

— end —

Canadian Pharmacy King Jailed – Georgios Xydeas

April 4, 2008

GREEK NATIONAL INDICTED FOR SELLING COUNTERFEIT, MISBRANDED AND UNAPPROVED PRESCRIPTION DRUGS TO INTERNET PHARMACIES AND UNDERCOVER AGENTS

ILLEGALLY IMPORTED DRUGS FOUND TO MAKE SOME RECIPIENTS ILL

DENVER – Troy A. Eid, United States Attorney for the District of Colorado, Jeffrey Copp, Special Agent in Charge of the Immigration and Customs Enforcement (ICE) office in Colorado, and Larry Sperl, Special Agent in Charge of the Food and Drug Administration’s Office of Criminal Investigations (FDA OCI) Kansas City Field Office, announced that GEORGIOS XYDEAS, age 47, a Greek national, appeared in U.S. District Court in Denver today for a detention hearing.  At the hearing U.S. Magistrate Judge Michael J. Watanabe ordered XYDEAS to be held without bond pending trial. XYDEAS had previously made his initial appearance in U.S. District Court on March 27, 2008, where he was advised of the charges pending against him.  He was arraigned on April 1, 2008.

XYDEAS’ prosecution is a culmination of a three-year investigation by ICE, the FDA/OCI and the United States Attorney’s Office into the operation of internet pharmacies that do not adhere to U.S. law, and their foreign sources of supply that send thousands of counterfeit, misbranded and unapproved prescription drugs into the U.S. illegally each year.  The investigation netted two firsts of its kind.

Cooperation with the Chinese government:  ICE and the FDA/OCI special agents, and a prosecutor from the United States Attorney’s Office, assisted the Chinese government in prosecuting Chinese citizens who were several sources of supply of the misbranded or counterfeit drugs.  The U.S. team in this case was the first contingent allowed to interview by proxy a suspect inside a Chinese detention facility, which directly led to identifying XYDEAS and several other foreign sources of supply.  In addition, Chinese authorities arrested 13 people and seized about 400 kilograms (880 pounds) of counterfeit Tamiflu and more than 40 tons of raw chemical materials.  This operation was touted by the Chinese authorities as one of the top three U.S.-Chinese cooperative law enforcement actions of 2006.

The unique facet to XYDEAS’ investigation and prosecution: Nearly all the components in this scheme, except for the U.S. customers, were foreign based, operating offshore.  Although the foreign-based aspect of this crime makes U.S. investigation and prosecution especially difficult, XYDEAS is being held accountable for his part in the scheme.

An arrest warrant based on a sealed criminal complaint filed in Denver was issued January 28, 2008.  On February 28, 2008, a federal grand jury in Denver returned an indictment, charging XYDEAS with forty three (43) criminal counts, including conspiracy, trafficking in counterfeit goods, importing controlled substances, misbranding of any food or drug, and smuggling goods into the U.S.  On March 8, 2008, XYDEAS was arrested in New York City after he was denied entry into Panama.

The XYDEAS portion of the investigation was initiated in part after the FDA issued a consumer warning in February 2007, stating that people ordering specific drugs from certain internet pharmacies were receiving the powerful anti-psychotic drug identified as Haloperidol, the active pharmaceutical ingredient found in Haldol, instead of the medication they ordered, which included Ambien, Xanax, Lexapro, and Ativan.  The warning stated that the misbranded drugs were shipped from Greece.  The FDA found that some recipients who took the misbranded drugs became ill, and had to seek medical attention.  (The FDA warning can be found athttp://www.fda.gov/bbs/topics/NEWS/2007/NEW01564.html).  Further investigation led agents to XYDEAS.

According to the affidavit in support of the criminal complaint and the indictment,XYDEAS was allegedly found to be a source of supply of unapproved prescription medications, including some controlled substances, for several internet website operators. With assistance from private industry, ICE and FDA/OCI agents determined that XYDEAS was illegally distributing in the U.S. misbranded or counterfeit prescription medication, such as Cialis, Ambien, Haldol, Xanax, Viagra, Ativan and Meridia.  On numerous occasions recipients received purported prescription medication which contained Haloperidol (a foreign version of Haldol), instead of the actual prescription drugs ordered by customers.  During a lengthy undercover operation, agents from ICE and FDA/OCI received several thousand tablets of counterfeit and unapproved drugs sent by or at the direction of XYDEAS.

“Counterfeit and misbranded prescription drugs are pouring into America from China and other countries.  We’re just beginning to learn how dangerous these drugs can be,” said U.S. Attorney Troy Eid.  “Working these investigations takes unprecedented international cooperation, but we’re committed to going the distance.”

“Importing any counterfeit, misbranded or unapproved pharmaceutical drug is a significant danger to the American public in many respects,” said Jeffrey Copp, special agent in charge of the ICE Office of Investigations in Denver.  “ICE will continue to partner with other law enforcement agencies to eliminate this threat, and to bring to justice the organized criminals who profit.”  Copp oversees a four-state area which includes: Colorado, Montana, Utah and Wyoming.

“Those that deal in counterfeit pharmaceuticals are solely motivated by greed and they prey upon an unsuspecting public with no regard for potentially placing the public’s health at risk.  We will continue to work with our law enforcement partners to pursue drug counterfeiters to the fullest extent of the law,” said Terry Vermillion, Director, FDA Office of Criminal Investigations.

XYDEAS faces:
*      Count one: conspiracy, which carries a penalty of not more than 5 years imprisonment, and up to a $250,000 fine.
*      Count two: conspiracy to import a Schedule IV controlled substance, which carries a penalty of not more than 5 years in federal prison, and up to a $250,000 fine.
*      Count three: conspiracy to distribute and possess with intent to distribute Schedule IV controlled substances, which carries a penalty of not more than 3 years imprisonment, and up to a $250,000 fine.
*      Count four and five: trafficking in counterfeit pharmaceutical drug, which carries a penalty of not more than 10 years in federal prison, and up to a $2,000,000 fine.
*      Count six: importation of Scheduled IV controlled substances, which carries a penalty of not more than 5 years imprisonment, and up to a $250,000 fine.
*      Count seven through nineteen: introduction an delivery for introduction of unapproved new drugs into interstate commerce, which carries a penalty of which carries a penalty of not more than 3 years imprisonment, and up to a $250,000 fine.

*      Count twenty through twenty nine: introduction and delivery for introduction of misbranded drugs into interstate commerce, which carries a penalty of not more than 3 years imprisonment, and up to a $250,000 fine.
*      Count thirty through forty two: importation of merchandise contrary to law, which carries a penalty of not more than 20 years imprisonment, and up to a $250,000 fine.

This case was investigated by agents from Immigration and Customs Enforcement (ICE), and the Food and Drug Administration’s Office of Criminal Investigations (FDA OCI), with support from the U.S. State Department and Panamanian officials and assistance from the Eli Lilly Pharmaceutical Co., the Sanofi-Aventis Pharmaceutical Co., the British Medicines and Health Care Regulatory Agency (MHRA).

This investigation was derived from the previous investigations of Northstar Pharmaceuticals (Criminal Case # 05-CR-376-RB) and Stephan FU (Criminal Case # 06-MJ-01180).

The case is being prosecuted by Assistant U.S. Attorney Ken Harmon.

The charges are only allegations, and the defendant is presumed innocent unless and until proven guilty.

###

NOTE:  No mug shot is available, as release of mug shots is prohibited by the Department of Justice.

For more information contact Jeff Dorschner of the U.S. Attorney’s Office at 303-454-0243.
For more information regarding ICE’s role contact Carl Rusnok of ICE  Public Affairs at 214-905-5292.
For more information regarding the FDA’s role contact Brad Swezy at 301-827-0954.

http://www.fda.gov/bbs/topics/NEWS/2007/NEW01564.html

http://www.fda.gov/bbs/topics/news/photos/haloperidol.html

Account Payable – mkjones0102@yahoo.com

Date: 2009-07-26, 7:23AM PDT
Reply to: mkjones0102@yahoo.com

Position Summary

Accounts Payable duties.

Essential Duties and Responsibilities
Print, assemble checks for signature signing and mail them out weekly.
Familiar with Excel, Word, and Microsoft Outlook.
Basic knowledge of accounting.
Education and Work Experience MINIMUM
Minimum of 1 years of Accounts Payable experience.

Please only replay is you qualify and agree to the salary.

Compensation: $800 – $1000/month
This is a part-time job.
Principals only. Recruiters, please don’t contact this job poster.
Please, no phone calls about this job!
Please do not contact job poster about other services, products or commercial interests.
PostingID: 1289589215